| HOME >> BIOLOGY >> TECHNOLOGY |
(Unaudited) (Unaudited)
Preservation services:
Cardiac tissue $6,348 $5,048 $12,586 $10,021
Vascular tissue 7,080 5,428 13,939 11,567
Orthopaedic tissue 297 1,235 624 3,084
Total preservation services 13,725 11,711 27,149 24,672
Products:
BioGlue 12,972 10,930 24,859 22,093
Other implantable medical devices 308 226 401 458
Total products 13,280 11,156 25,260 22,551
Other 150 144 314 312
Total revenues $27,155 $23,011 $52,723 $47,535
Revenues:
Domestic revenues $22,833 $19,410 $44,833 $40,812
International revenues 4,322 3,601 7,890 6,723
Total revenues $27,155 $23,011 $52,723 $47,535
June 30, December 31,
2008 2007
(Unaudited)
Cash and cash equivalents, marketable securities, $12,282 $17,447
at market, and restricted marketable securities
Trade receivables, net 14,040 12,311
Other receivables 1,035 1,373
Deferred preservation costs, net 31,443 26,903
Inventories 6,254 5,607
Restricted money market funds, long-term 5,000 --
Total assets 98,096 92,684
Shareholders' equity
'/>"/>
| SOURCE CryoLife, Inc. Copyright©2008 PR Newswire. All rights reserved |